These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34054051)

  • 21. Adherence to hydroxyurea, health-related quality of life domains and attitudes towards a smartphone app among Irish adolescents and young adults with sickle cell disease.
    Fogarty H; Gaul A; Syed S; Aleksejenko N; Geoghegan R; Conroy H; Crampton E; Ngwenya N; Tuohy E; McMahon C
    Ir J Med Sci; 2022 Apr; 191(2):809-816. PubMed ID: 33745105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxyurea therapy in adult Nigerian sickle cell disease: a monocentric survey on pattern of use, clinical effects and patient's compliance.
    Adewoyin AS; Oghuvwu OS; Awodu OA
    Afr Health Sci; 2017 Mar; 17(1):255-261. PubMed ID: 29026400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of Medical Student Mentors to Improve Transition in Sickle Cell Disease.
    Viola AS; Drachtman R; Kaveney A; Sridharan A; Savage B; Delnevo CD; Coups EJ; Porter JS; Devine KA
    J Pediatr Psychol; 2021 Jul; 46(6):650-661. PubMed ID: 33779756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transition to adult care in sickle cell disease: A longitudinal study of clinical characteristics and disease severity.
    Kayle M; Docherty SL; Sloane R; Tanabe P; Maslow G; Pan W; Shah N
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27463. PubMed ID: 30251318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to Quality of Care Indicators and Location of Sickle Cell Care Within Indiana.
    Meier ER; Janson IA; Hampton K; Bloom E; Duncan N; Roberson C; Rampersad A
    J Community Health; 2020 Feb; 45(1):81-87. PubMed ID: 31396825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized feasibility trial to improve hydroxyurea adherence in youth ages 10-18 years through community health workers: The HABIT study.
    Green NS; Manwani D; Matos S; Hicks A; Soto L; Castillo Y; Ireland K; Stennett Y; Findley S; Jia H; Smaldone A
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desire for parenthood and reproductive health knowledge in adolescents and young adults with sickle cell disease and their caregivers.
    Nahata L; Caltabellotta NM; Ball K; O'Brien SH; Creary SE
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28944997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perception to hydroxyurea therapy in patients with sickle cell disease: Report from 3 centers.
    Korubo KI; Onodingene NM; Okoye HC; Omunakwe HE
    Ann Afr Med; 2021; 20(2):127-131. PubMed ID: 34213480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and evaluation of iManage: A self-management app co-designed by adolescents with sickle cell disease.
    Crosby LE; Ware RE; Goldstein A; Walton A; Joffe NE; Vogel C; Britto MT
    Pediatr Blood Cancer; 2017 Jan; 64(1):139-145. PubMed ID: 27574031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Provider Attitudes, Preferences, and Practices Regarding Sexual and Reproductive Health for Adolescents and Young Adults With Sickle Cell Disease.
    Leroy-Melamed M; Jacob S; Shew ML; Kazmerski TM
    J Adolesc Health; 2021 Dec; 69(6):970-975. PubMed ID: 34294508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease.
    Kang HA; Barner JC
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1412-1422. PubMed ID: 33119448
    [No Abstract]   [Full Text] [Related]  

  • 34. An Electronic Teaching Module for Improving Knowledge of Self-Management of Vaso-Occlusive Pain Crises in Patients With Sickle Cell Disease: Pilot Questionnaire Study.
    Tam T; Baer MR; Hsu LL; Law JY
    JMIR Mhealth Uhealth; 2019 Jun; 7(6):e13501. PubMed ID: 31223120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network.
    Lanzkron S; Haywood C; Hassell KL; Rand C
    J Natl Med Assoc; 2008 Aug; 100(8):968-73. PubMed ID: 18717150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease.
    Candrilli SD; O'Brien SH; Ware RE; Nahata MC; Seiber EE; Balkrishnan R
    Am J Hematol; 2011 Mar; 86(3):273-7. PubMed ID: 21328441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.
    Galadanci NA; Abdullahi SU; Tabari MA; Abubakar S; Belonwu R; Salihu A; Neville K; Kirkham F; Inusa B; Shyr Y; Phillips S; Kassim AA; Jordan LC; Aliyu MH; Covert BV; DeBaun MR
    Pediatr Blood Cancer; 2015 Mar; 62(3):395-401. PubMed ID: 25399822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A feasibility study of telemedicine for paediatric sickle cell patients living in a rural medically underserved area.
    Jacob SA; Carroll AE; Bennett WE
    J Telemed Telecare; 2021 Aug; 27(7):431-435. PubMed ID: 31694482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.